TCL Archive Early-Stage HER2+ Breast Cancer Patients Are At Significant Risk Of Recurrence December 26, 2008
TCL Archive Majority Of Physicians Support Clinical Alert, But some NCAB Members Still Not Convinced November 18, 1988
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive NIEHS Awards $5M Grant for New Health Sciences Center to Robert Wood Johnson Medical School January 20, 1989
TCL Archive Number of Clinical R01 Applications Doubles; Funding Rate Below 20%; NCI Execs Not Satisfied July 17, 1992
